The microbiota and inflammatory bowel disease: Insights from animal models

Anaerobe

Volumn 24, Issue , 2013, Pages 102-106

  Peloquin, Joanna M ^a,b   Nguyen, Deanna D ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Animal models; Colitis; Inflammatory bowel disease; Microbiota

Indexed keywords

CBIR1 PROTEIN; FLAGELLIN; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDES FRAGILIS; CLOSTRIDIUM; COLITIS; DISEASE MODEL; ENTERITIS; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALIA; BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; CLOSTRIDIUM; HELICOBACTER; MURINAE; MUS;

ANIMAL MODELS; COLITIS; INFLAMMATORY BOWEL DISEASE; MICROBIOTA;

ANIMALS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE; MICROBIOTA;

EID: 84889096652     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.04.006     Document Type: Article

References (44)

1. Spehlmann M.E., Begun A.Z., Burghardt J., Lepage P., Raedler A., Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008, 14:968-976.
2. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
3. Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
4. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317.
5. Anderson C.A., Boucher G., Lees C.W., Franke A., D'Amato M., Taylor K.D., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011, 43:246-252.
6. Garrett W.S., Gordon J.I., Glimcher L.H. Homeostasis and inflammation in the intestine. Cell 2010, 140:859-870.
7. Mombaerts P., Mizoguchi E., Grusby M.J., Glimcher L.H., Bhan A.K., Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993, 75:274-282.
8. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261.
9. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
10. Blumberg R., Powrie F. Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 2012, 4. 137rv7.
11. Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 2012, 105:263-320.
12. Mizoguchi A., Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. JGastroenterol 2008, 43:1-17.
13. Berg D.J., Davidson N., Kuhn R., Muller W., Menon S., Holland G., et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. JClin Invest 1996, 98:1010-1020.
14. Blumberg R.S., Saubermann L.J., Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999, 11:648-656.
15. Madsen K.L., Doyle J.S., Tavernini M.M., Jewell L.D., Rennie R.P., Fedorak R.N. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000, 118:1094-1105.
16. Kang S.S., Bloom S.M., Norian L.A., Geske M.J., Flavell R.A., Stappenbeck T.S., et al. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med 2008, 5:e41.
17. Garrett W.S., Lord G.M., Punit S., Lugo-Villarino G., Mazmanian S.K., Ito S., et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007, 131:33-45.
18. Foltz C.J., Fox J.G., Cahill R., Murphy J.C., Yan L., Shames B., et al. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 1998, 3:69-78.
19. Cahill R.J., Foltz C.J., Fox J.G., Dangler C.A., Powrie F., Schauer D.B. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997, 65:3126-3131.
20. Ward J.M., Anver M.R., Haines D.C., Melhorn J.M., Gorelick P., Yan L., et al. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab Anim Sci 1996, 46:15-20.
21. Fox J.G., Ge Z., Whary M.T., Erdman S.E., Horwitz B.H. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol 2011, 4:22-30.
22. Shomer N.H., Dangler C.A., Schrenzel M.D., Fox J.G. Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun 1997, 65:4858-4864.
23. Erdman S.E., Poutahidis T., Tomczak M., Rogers A.B., Cormier K., Plank B., et al. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003, 162:691-702.
24. Maggio-Price L., Bielefeldt-Ohmann H., Treuting P., Iritani B.M., Zeng W., Nicks A., et al. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am J Pathol 2005, 166:1793-1806.
25. Maggio-Price L., Treuting P., Zeng W., Tsang M., Bielefeldt-Ohmann H., Iritani B.M. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 2006, 66:828-838.
26. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
27. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., et al. Bacterial flagellin is a dominant antigen in Crohn disease. JClin Invest 2004, 113:1296-1306.
28. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. JBiol Chem 2003, 278:5509-5512.
29. Hand T.W., Dos Santos L.M., Bouladoux N., Molloy M.J., Pagan A.J., Pepper M., et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 2012.
30. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
31. Ivanov I.I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
32. Davis C.P., Savage D.C. Habitat, succession, attachment, and morphology of segmented, filamentous microbes indigenous to the murine gastrointestinal tract. Infect Immun 1974, 10:948-956.
33. Umesaki Y., Setoyama H., Matsumoto S., Imaoka A., Itoh K. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun 1999, 67:3504-3511.
34. Talham G.L., Jiang H.Q., Bos N.A., Cebra J.J. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 1999, 67:1992-2000.
35. Klaasen H.L., Van der Heijden P.J., Stok W., Poelma F.G., Koopman J.P., Van den Brink M.E., et al. Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun 1993, 61:303-306.
36. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
37. Leppkes M., Becker C., Ivanov, Hirth S., Wirtz S., Neufert C., et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009, 136:257-267.
38. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
39. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104:13780-13785.
40. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009, 15:1183-1189.
41. Ciorba M.A., Bettonville E.E., McDonald K.G., Metz R., Prendergast G.C., Newberry R.D., et al. Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis. JImmunol 2010, 184:3907-3916.
42. Matteoli G., Mazzini E., Iliev I.D., Mileti E., Fallarino F., Puccetti P., et al. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010, 59:595-604.
43. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010, 107:12204-12209.
44. Mazmanian S.K., Round J.L., Kasper D.L. Amicrobial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.